More than a third of patients with cancer report experiencing "moderate-to-severe cancer-related pain;” 40% of these patients experience “breakthrough pain” on their pain regimens. Opioid analgesics remain the mainstay for the treatment of moderate-to-severe cancer-associated pain. There is a new meta-analysis concerning opioid efficacy in this setting.
Buckle up; it's going to be a rough night.
